Martin Bjerregård Pedersen

1.4k total citations
25 papers, 438 citations indexed

About

Martin Bjerregård Pedersen is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology. According to data from OpenAlex, Martin Bjerregård Pedersen has authored 25 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 8 papers in Genetics and 7 papers in Immunology. Recurrent topics in Martin Bjerregård Pedersen's work include Lymphoma Diagnosis and Treatment (16 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and T-cell and Retrovirus Studies (4 papers). Martin Bjerregård Pedersen is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and T-cell and Retrovirus Studies (4 papers). Martin Bjerregård Pedersen collaborates with scholars based in Denmark, United States and Germany. Martin Bjerregård Pedersen's co-authors include Francesco d’Amore, Paolo Corradini, W. S. Kim, Philippe Gaulard, Lorenz Trümper, Marco Ladetto, Lena Specht, Knud Bendix, Michael Møller and Peter Nørgaard and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Martin Bjerregård Pedersen

21 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Bjerregård Pedersen Denmark 9 265 180 171 79 65 25 438
Ivonne A. Montes‐Mojarro Germany 11 264 1.0× 118 0.7× 253 1.5× 53 0.7× 55 0.8× 24 448
Zhengzi Qian China 10 197 0.7× 99 0.6× 179 1.0× 22 0.3× 120 1.8× 29 415
Colin Phipps Singapore 8 353 1.3× 250 1.4× 344 2.0× 50 0.6× 73 1.1× 17 543
Jianqiu Wu China 12 124 0.5× 114 0.6× 263 1.5× 16 0.2× 130 2.0× 35 494
Huangming Hong China 10 191 0.7× 97 0.5× 237 1.4× 15 0.2× 212 3.3× 51 554
Yunfei Shi China 14 194 0.7× 116 0.6× 219 1.3× 15 0.2× 150 2.3× 39 520
Silvia Mappa Italy 10 312 1.2× 38 0.2× 158 0.9× 76 1.0× 78 1.2× 27 442
Matteo Dell’Olio Italy 14 378 1.4× 142 0.8× 274 1.6× 19 0.2× 77 1.2× 30 624
Edward F. Schnipper United States 6 140 0.5× 208 1.2× 133 0.8× 96 1.2× 64 1.0× 6 492
Aleš Obr Czechia 8 366 1.4× 74 0.4× 384 2.2× 42 0.5× 38 0.6× 21 483

Countries citing papers authored by Martin Bjerregård Pedersen

Since Specialization
Citations

This map shows the geographic impact of Martin Bjerregård Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bjerregård Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bjerregård Pedersen more than expected).

Fields of papers citing papers by Martin Bjerregård Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bjerregård Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bjerregård Pedersen. The network helps show where Martin Bjerregård Pedersen may publish in the future.

Co-authorship network of co-authors of Martin Bjerregård Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bjerregård Pedersen. A scholar is included among the top collaborators of Martin Bjerregård Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bjerregård Pedersen. Martin Bjerregård Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Martin Bjerregård, et al.. (2025). Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series. Acta Dermato Venereologica. 105. adv40952–adv40952.
2.
Steffensen, Lasse Bach, Martin Bjerregård Pedersen, Martin J. Larsen, et al.. (2025). Mutational landscape of atherosclerotic plaques reveals large clonal cell populations. JCI Insight. 10(10). 3 indexed citations
3.
Pedersen, Martin Bjerregård, Mette K. Andersen, Erika Frischknecht Christensen, et al.. (2025). Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trials. Journal of Reproductive Immunology. 170. 104541–104541.
4.
Pedersen, Martin Bjerregård, et al.. (2025). Revisiting the Link Between Factor XII and Recurrent Pregnancy Loss: A Scoping Review. American Journal of Reproductive Immunology. 94(2). e70127–e70127.
5.
Pedersen, Martin Bjerregård, Marcus Høy Hansen, Trine Lindhardt Plesner, et al.. (2024). Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma. Haematologica. 109(12). 4067–4072.
6.
Plesner, Trine Lindhardt, et al.. (2021). Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation. SHILAP Revista de lepidopterología. 2021. 1–5. 5 indexed citations
7.
Pedersen, Martin Bjerregård, Michael Roost Clausen, Henrik Frederiksen, et al.. (2021). Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia. Cancers. 13(21). 5526–5526. 6 indexed citations
8.
Ludvigsen, Maja, Martin Bjerregård Pedersen, Tim Svenstrup Poulsen, et al.. (2018). Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Blood Advances. 2(19). 2533–2542. 13 indexed citations
9.
Plesner, Trine Lindhardt, Martin Bjerregård Pedersen, Maja Ludvigsen, et al.. (2017). Lympho- and Myeloproliferative Malignancies Occurring in the Same Host: Description of a Nationwide Discovery Cohort. 1 indexed citations
10.
Pedersen, Martin Bjerregård, et al.. (2017). The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study. British Journal of Haematology. 178(5). 739–746. 23 indexed citations
11.
Pedersen, Martin Bjerregård, Knud Bendix, Rhett P. Ketterling, et al.. (2017). DUSP22 AND TP63 REARRANGEMENTS PREDICT OUTCOME OF ALK‐NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: A DANISH COHORT STUDY. Hematological Oncology. 35(S2). 391–392. 1 indexed citations
12.
El‐Galaly, Tarec Christoffer, Martin Bjerregård Pedersen, Martin Hutchings, et al.. (2015). Utility of interim and end‐of‐treatment PET/CT in peripheral T‐cell lymphomas: A review of 124 patients. American Journal of Hematology. 90(11). 975–980. 43 indexed citations
13.
d’Amore, Francesco, Philippe Gaulard, Lorenz Trümper, et al.. (2015). Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 26. v108–v115. 129 indexed citations
14.
Madsen, Charlotte Bernhard, Martin Bjerregård Pedersen, Knud Bendix, et al.. (2014). Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Annals of Oncology. 26(2). 393–399. 32 indexed citations
15.
Pedersen, Martin Bjerregård, Stephen Hamilton‐Dutoit, Knud Bendix, et al.. (2014). High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma. Histopathology. 65(4). 490–500. 45 indexed citations
16.
Pedersen, Martin Bjerregård, Rikke Riber‐Hansen, Patricia Switten Nielsen, et al.. (2014). Digital Pathology for the Validation of Tissue Microarrays in Peripheral T-cell Lymphomas. Applied immunohistochemistry & molecular morphology. 22(8). 577–584. 5 indexed citations
17.
Pedersen, Martin Bjerregård, Stephen Hamilton‐Dutoit, Knud Bendix, et al.. (2014). Evaluation of clinical trial eligibility and prognostic indices in a population‐based cohort of systemic peripheral T‐cell lymphomas from the Danish Lymphoma Registry. Hematological Oncology. 33(4). 120–128. 8 indexed citations
18.
O’Connor, Owen A., Govind Bhagat, Karthik A. Ganapathi, et al.. (2014). Changing the Paradigms of Treatment in Peripheral T-cell Lymphoma: From Biology to Clinical Practice. Clinical Cancer Research. 20(20). 5240–5254. 34 indexed citations
19.
El‐Galaly, Tarec Christoffer, Karen Juul Mylam, Maria Rossing, et al.. (2013). Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse. Hematological Oncology. 31. 1 indexed citations
20.
Pedersen, Martin Bjerregård, Xingfei Zhou, E. Larsen, et al.. (2010). Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation. The Journal of Immunology. 184(4). 1931–1945. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivonne A. Montes‐Mojarro Breakdown of academic impact, for papers by Zhengzi Qian Breakdown of academic impact, for papers by Colin Phipps Breakdown of academic impact, for papers by Jianqiu Wu Breakdown of academic impact, for papers by Huangming Hong Breakdown of academic impact, for papers by Yunfei Shi Breakdown of academic impact, for papers by Silvia Mappa Breakdown of academic impact, for papers by Matteo Dell’Olio Breakdown of academic impact, for papers by Edward F. Schnipper Breakdown of academic impact, for papers by Aleš Obr
Rankless by CCL
2026